Tag Archives: DEA

Should Kratom Become a Schedule I Drug?

On August 31, 2016, the Drug Enforcement Administration (DEA) temporarily placed mitragynine and 7-hydroxymitragynine into Schedule I status, then withdrew the intent to schedule in favor of a public comment period until December 1, 2016. The status of Kratom remains undetermined. Mitragynine and 7-hydroxymitragynine are the active alkaloids…

Read More